This inventor holds 1 USPTO granted patent. Top assignee: Covidien LP. Active years: 2022.
Company Filing History:
Years Active: 2022
Title: Erin F McLaughlin: Innovator in High Flow Oxygen Therapy
Introduction
Erin F McLaughlin is a notable inventor based in Langley, Canada. She has made significant contributions to the field of respiratory therapy, particularly through her innovative patent related to high flow oxygen therapy. Her work is essential in improving patient care and monitoring in medical settings.
Latest Patents
Erin holds a patent for a "System and method for high flow oxygen therapy." This invention involves a method of high flow oxygen therapy (HFOT) and carbon dioxide (CO2) monitoring. The system delivers high flow oxygen therapy via a central lumen of a nasal cannula, which is designed to be positioned within a patient's airway. The method includes receiving sampled exhaled breath through a sampling lumen, allowing for accurate monitoring of CO2 levels in the patient's breath.
Career Highlights
Erin is currently employed at Covidien LP, a company known for its medical devices and technologies. Her role at Covidien LP allows her to apply her innovative ideas in a practical setting, contributing to advancements in healthcare.
Collaborations
Throughout her career, Erin has collaborated with several professionals, including Mark A McGann and Kieran M Donlon. These collaborations have likely enhanced her work and contributed to the development of her patented technologies.
Conclusion
Erin F McLaughlin is a pioneering inventor whose work in high flow oxygen therapy has the potential to transform patient care. Her innovative approach and dedication to improving respiratory therapy are commendable.